Skip to main content
Clinical Trials/NCT05738278
NCT05738278
Recruiting
Not Applicable

Heart Rate Informed Changes in Care for Non-Communicating Patients: A Randomized Controlled Trial

University of Oslo2 sites in 1 country38 target enrollmentStarted: February 27, 2023Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
38
Locations
2
Primary Endpoint
Situations identified by 2 standard deviation increase in HR

Overview

Brief Summary

The overarching aim is to generate knowledge to reduce incidence of pain in non-verbal patients' everyday life. The trial will 1) evaluate how HR can be used to identify potentially painful care procedures that should be re-evaluated in terms of the approach taken; 2) test the effect of heart rate (HR)-informed changes in potentially painful care procedures on biomarkers of pain, and 3) assess how six weeks of communication through HR affects the quality of communication between patient and caregiver.

Detailed Description

Detailed protocol to be published as journal article with reference to Clinicaltrials.gov-registration. Preprint available: https://osf.io/gan42

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Masking Description

Due to the objectives of the study, the identity of test and control treatments will not be known when analysing data. Access to the randomization code will be strictly controlled.

Eligibility Criteria

Ages
5 Years to 70 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Between 5 and 70 years of age at the time of data collection
  • Autism spectrum disorder as evaluated by clinical psychologist
  • Communication difficulties
  • Living at a care home with round-the-clock staff for at least five days a week; or attending one-to-one staffed school/day-care at least five days a week.
  • Written informed consent is obtained from the subjects' legal representative.

Exclusion Criteria

  • Having any autoimmune disorder or any type of cancer with ongoing chemotherapy.

Outcomes

Primary Outcomes

Situations identified by 2 standard deviation increase in HR

Time Frame: 11 weeks

The hypothesis is that a 2 standard deviation increase in HR can identify potentially painful care situations that require re-evaluation. Mean HR spike counts will be compared using a one-tailed paired sampled t-test to differentiate between suitable and unsuitable situations for care adjustments.

Secondary Outcomes

  • HRV (ms)(6 weeks)
  • Serum concentrations of MCP-1, IL-1RA, IL-8, TGFβ1, and IL-17 (pg/ml)(6 weeks)
  • Scores on quality of communication(6 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Bjørnar Hassel

Professor

University of Oslo

Study Sites (2)

Loading locations...

Similar Trials